US-based PE firm, Advent, is investing US$$175m via primary and secondary for a significant minority stake in Dublin headquartered Felix Pharmaceuticals, a developer and manufacturer of off-patent medicines for companion…
India: Advent partners with Felix to build generic animal health leader
…
…



